Stock 6492 SENHWA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Senhwa Biosciences, Inc.

Equities

6492

TW0006492002

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
41.7 TWD +0.24% Intraday chart for Senhwa Biosciences, Inc. +0.24% -18.07%
03-20 Senhwa Biosciences Announces First Patient Dosed in the Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia Associated with Viral Infection in Taiwan CI
03-14 Senhwa Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Senhwa Biosciences, Inc. is a Taiwan-based company principally engaged in the research and development of anti-cancer new drugs and special drug substances. The Company's main development projects include the CX-5461, for the treatment of hematologic cancers and breast cancers, as well as the CX-4945, for the treatment of cholangiocarcinoma. The Company has not generated any revenues yet.

Sales per Business

TWD in Million2022Weight2023Weight Delta
New Drugs and Special Raw Material Drugs
100.0 %
1 100.0 % 1 100.0 % 0.00%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
1 100.0 % 1 100.0 % 0.00%

Managers

Managers TitleAgeSince
Tai Sen Soong CEO
 Chief Executive Officer - 12-11-15
Hsiao Ping Chang DFI
 Director of Finance/CFO - 12-12-31

Members of the board

Members of the board TitleAgeSince
Tai Sen Soong CEO
 Chief Executive Officer - 12-11-15
Chia Hung Li BRD
 Director/Board Member - 15-03-08
Benny Hu CHM
 Chairman 75 11-12-31
Kuo Hsiang Li BRD
 Director/Board Member - 15-03-08
Hung Min Hsieh BRD
 Director/Board Member - 12-11-15
Yu Chih Chang BRD
 Director/Board Member - 15-03-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 89,744,000 66,889,620 ( 74.53 %) 558,000 ( 0.6218 %) 74.53 %

Company contact information

Senhwa Biosciences, Inc.

10th Floor No. 225 Peihsin Road Section 3

23143, New Taipei

+

http://www.senhwabiosciences.com
address Senhwa Biosciences, Inc.(6492)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
SENHWA BIOSCIENCES, INC. Stock Senhwa Biosciences, Inc.
-18.07% 116M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+7.52% 113B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.38% 106B
ARGENX SE Stock argenx SE
+1.48% 22.27B
BIONTECH SE Stock BioNTech SE
-12.64% 22.22B
GENMAB A/S Stock Genmab A/S
-5.10% 19.43B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.85% 17.87B
BEIGENE, LTD. Stock BeiGene, Ltd.
-8.58% 17.24B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.77% 14.29B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.41% 12.52B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6492 Stock
  4. Company Senhwa Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW